Keywords
Exploration
Accueil
Racine
Exploration
Accueil
Racine

Movement Disorders (revue) - Exploration (Accueil)

Index « Keywords » - entrée « Adrenergic alpha-Antagonists (therapeutic use) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Adrenergic alpha-Antagonists (pharmacology) < Adrenergic alpha-Antagonists (therapeutic use) < Adrenergic beta-Agonists (pharmacology)  Facettes :

List of bibliographic references indexed by Adrenergic alpha-Antagonists (therapeutic use)

Number of relevant bibliographic references: 7.
Ident.Authors (with country if any)Title
003382 (2006) Takashi Ito [Japon] ; Ryuji Sakakibara [Japon] ; Kosaku Yasuda [Japon] ; Tatsuya Yamamoto [Japon] ; Tomoyuki Uchiyama [Japon] ; Zhi Liu [Japon] ; Tomonori Yamanishi [Japon] ; Yusuke Awa [Japon] ; Kaori Yamamoto [Japon] ; Takamichi Hattori [Japon]Incomplete emptying and urinary retention in multiple‐system atrophy: When does it occur and how do we manage it?
003706 (2005) Gregor K. Wenning [Autriche] ; Felix Geser [Autriche] ; Werner Poewe [Autriche]Therapeutic strategies in multiple system atrophy
004085 (2003) Juha-Matti Savola [Finlande] ; Michael Hill [Royaume-Uni] ; Mia Engstrom [Finlande] ; Hannele Merivuori [Finlande] ; Siegfried Wurster [Finlande] ; Steven G. Mcguire [Royaume-Uni] ; Susan H. Fox [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni] ; Jonathan M. Brotchie [Royaume-Uni, Canada]Fipamezole (JP‐1730) is a potent α2 adrenergic receptor antagonist that reduces levodopa‐induced dyskinesia in the MPTP‐lesioned primate model of Parkinson's disease
004780 (2001) Olivier Rascol [France] ; I. Arnulf [France] ; H. Peyro-Saint Paul [France] ; C. Brefel-Courbon [France] ; M. Vidailhet [France] ; C. Thalamas [France] ; A. M. Bonnet [France] ; S. Descombes [France] ; B. Bejjani [France] ; N. Fabre [France] ; J. L. Montastruc [France] ; Yves Agid [France]Idazoxan, an alpha‐2 antagonist, and L‐DOPA‐induced dyskinesias in patients with Parkinson's disease
004A57 (2000) Alice J. Manson [Royaume-Uni] ; Elena Iakovidou [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]Idazoxan is ineffective for levodopa‐induced dyskinesias in Parkinson's disease
004E40 (1999) J. M. Brotchie [Royaume-Uni] ; S. H. Fox [Royaume-Uni]Quantitative assessment of dyskinesias in subhuman primates
005020 (1998) Rascol [France] ; Kasia Sieradzan [Royaume-Uni] ; Hélène Peyro-Saint-Paul [France] ; Claire Thalamas [France] ; Christine Brefel-Courbon [France] ; Jean Michel Senard [France] ; Philippe Ladure [France] ; Jean Louis Montastruc [France] ; Andrew Lees (neurologue) [Royaume-Uni]Efaroxan, an alpha‐2 antagonist, in the treatment of progressive supranuclear palsy

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Adrenergic alpha-Antagonists (therapeutic use)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Adrenergic alpha-Antagonists (therapeutic use)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Adrenergic alpha-Antagonists (therapeutic use)
}}
Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024